EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | CH4O3S.C19H18ClN5 |
| Net Charge | 0 |
| Average Mass | 447.948 |
| Monoisotopic Mass | 447.11319 |
| SMILES | CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2.CS(=O)(=O)O |
| InChI | InChI=1S/C19H18ClN5.CH4O3S/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18;1-5(2,3)4/h3-10H,11-12H2,1-2H3;1H3,(H,2,3,4) |
| InChIKey | FENBITQPWFCMEB-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| adinazolam mesylate (CHEBI:752148) is a triazolobenzodiazepine (CHEBI:35501) |
| Synonyms | Source |
|---|---|
| Adinazolam methanesulfonate | ChEMBL |
| U-41,123F | ChEMBL |
| U-41123F | ChEMBL |